Research article
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Arthritis Research & Therapy 2011, 13:R177 doi:10.1186/ar3502
Accesses
- Last 30 days: 145 accesses
- Last 365 days: 1439 accesses
- All time: 2496 accesses

